⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11776102 | 0.84 | — | — | |
| SCHEMBL31096364 | 0.69 | — | — | |
| SCHEMBL1781070 | 0.65 | — | — | |
| SCHEMBL8068777 | 0.65 | — | — | |
| SCHEMBL512359 | 0.65 | — | — | |
| SCHEMBL9187316 | 0.65 | — | — | |
| SCHEMBL2568694 | 0.65 | — | — | |
| SCHEMBL1277405 | 0.65 | — | — | |
| SCHEMBL1451452 | 0.65 | — | — | |
| SCHEMBL2247304 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090105482-A1 | Urea Glucokinase Activators | NOVO NORDISK A/S (DK) | 2009-04-23 | — | — | US | claimed |
| JP-2009501198-A | — | — | 2009-01-15 | — | — | JP | claimed |
| EP-1904467-A1 | UREA GLUCOKINASE ACTIVATORS | Novo Nordisk A/S (DK) | 2008-04-02 | — | — | EP | claimed |
| WO-2007006814-A1 | UREA GLUCOKINASE ACTIVATORS | NOVO NORDISK A/S (DK) | 2007-01-18 | — | — | WO | claimed |
| EP-0558104-B1 | 1,5-Benzodiazepine derivatives and their use in medicine | GLAXO WELLCOME SPA (IT) | 1998-07-29 | — | — | EP | claimed |
| US-5637697-A | ANTAGONIST TO GASTRIN AND(OR) CHLOROCYSTOKININ | GLAXO SPA (IT) | 1997-06-10 | — | — | US | claimed |
| US-5580895-A | GASTROINTESTINAL OR CENTRAL NERVOUS SYSTEM DISORDERS | GLAXO SPA (IT) | 1996-12-03 | — | — | US | claimed |
| EP-0558104-A1 | 1,5-Benzodiazepine derivatives and their use in medicine | GLAXO S.p.A. (IT) | 1993-09-01 | — | — | EP | claimed |
| WO-1993014074-A1 | 1,5-BENZODIAZEPINE DERIVATIVES AND THEIR USE IN MEDICINE | GLAXO SPA (IT) | 1993-07-22 | — | — | WO | claimed |
| US-4916255-A | Method for production of methacrylate ester | HITACHI, LTD. (JP) | 1990-04-10 | — | — | US | claimed |
| CN-114401966-A | Method for producing cyclic imide compound, composition, compound | 富士胶片株式会社 | 2022-04-26 | — | — | CN | disclosed |
| CN-113728449-A | Composition comprising a metal oxide and a metal oxide | 富士胶片株式会社 | 2021-11-30 | — | — | CN | disclosed |
| US-9605118-B2 | Film and method for manufacturing the same, optical film, polarizer-protecting film, polarizing plate, and image display device | FUJIFILM CORPORATION (JP) | 2017-03-28 | — | — | US | disclosed |
| US-8586614-B2 | Urea glucokinase activators | NOVO NORDISK A/S (DK) | 2013-11-19 | — | — | US | disclosed |
| EP-2377856-A1 | Urea glucokinase activators | NOVO NORDISK A/S (DK) | 2011-10-19 | — | — | EP | disclosed |
| EP-0432939-A2 | Oil soluble amino-substituted polymers containing graft polymer segments derived form aromatic nitrogen-containing monomers | EXXON CHEMICAL PATENTS INC. (US) | 1991-06-19 | — | — | EP | disclosed |
| US-4987200-A | METALLIZATION BEFORE POLYMERIZATION | EXXON CHEMICAL PATENTS INC. (US) | 1991-01-22 | — | — | US | disclosed |
| EP-0295076-A1 | Polyolefins incorporating functional groups, masked functional group-containing monomers, reaction mixtures, and methods for preparing same | EXXON CHEMICAL PATENTS INC. (US) | 1988-12-14 | — | — | EP | disclosed |
| US-4552888-A | Ascorbic acid ethers in angiogene | ELI LILLY AND COMPANY (US) | 1985-11-12 | — | — | US | disclosed |
| EP-0086554-A1 | Ascorbic acid ethers and related compounds | ELI LILLY AND COMPANY (US) | 1983-08-24 | — | — | EP | disclosed |